|Description||4-CMTB has been found to be a free fatty acid receptor FFA2 agonist and could modulate the activity of short-chain fatty acids.|
|Purity||≥98% by HPLC|
TUG424 is a a potent and selective free fatty acid receptor 1 agonist. It is expected to be useful in the exploration of FFA1 and may also be valuable as a lead...
GW9508 is a potent and selective agonist for FFA1 (GPR40) with pEC50 of 7.32, 100-fold selective against GPR120, and stimulates insulin secretion in a glucose-s...
AS 2034178 has been found to be a FFA1/GPR40 agonist and could probably be used against diabetes.
AMG 837 hemicalcium salt
The calcuim salt form of AMG 837, which has been found to be a GPR40 partial agonist and could probably be used as an antidiabetic agent.
MEDICA 16 is a selective free fatty acid 1 receptor agonist. It is also an ATP citrate lyase inhibitor. MEDICA 16 shows hypolipidemic and antidiabetogenic effec...
TUG-770 displayed excellent physicochemical and in vitro ADME properties, with good aqueous solubility, good chemical stability, low lipophilicity, and decrease...
AM4668 is a potent and selective G-protein coupled receptor 40(GPR40) agonist with EC50 value of 3.6 nM in an IP3 assay in GPR40 transfected A9 cells. It is mor...
4-CMTB has been found to be a free fatty acid receptor FFA2 agonist and could modulate the activity of short-chain fatty acids.